BIOGEN INC. (BIIB) Revenue 2016–2025
BIOGEN INC. (BIIB) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$9.9BFY2025 · since FY2016: $11.4B → $9.9B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $9.9B | +2.2% |
| FY2024 | $9.7B | -1.6% |
| FY2023 | $9.8B | -3.3% |
| FY2022 | $10.2B | -7.4% |
| FY2021 | $11.0B | -18.3% |
| FY2020 | $13.4B | -6.5% |
| FY2019 | $14.4B | +6.9% |
| FY2018 | $13.5B | +9.6% |
| FY2017 | $12.3B | +7.2% |
| FY2016 | $11.4B | — |
Source: SEC XBRL filings · For reference only · Not investment advice